Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Oncoimmunology|March 4, 2021
Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancerElise F Nassif, Constance Thibault, Stéphane Oudard, et al.Expert Review of Anticancer Therapy|February 14, 2019
Brain metastases and treatment: multiplying cognitive toxicitiesElise F Nassif, Alexandre Arsène-Henry, Youlia M KirovaCurrent Treatment Options in Oncology|February 28, 2023
Myxoid Liposarcomas: Systemic Treatment OptionsElise F Nassif, Emily Z Keung, Prapassorn Thirasastr, et al.Frontiers in Immunology|December 20, 2021
Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored ReviewMatthieu Roulleaux Dugage, Elise F Nassif, Antoine Italiano, et al.Frontiers in Medicine|September 30, 2021
Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case ReportElise F Nassif, Nolan Maloney, Anthony P Conley, et al.Current Oncology (Toronto, Ont.)|February 24, 2023
The Landscape of Immunotherapy for Retroperitoneal SarcomaAlicia A Gingrich, Elise F Nassif, Christina L Roland, et al.Cancers|January 28, 2026
First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic ReviewIlma Khan, Priyal Agarwal, Nassar El Assaad, et al.JCEM Case Reports|June 1, 2026
Ectopic ACTH syndrome in an adult with metastatic Ewing sarcomaDeborah A Osafehinti, Jennifer M Kaplan, Elise F Nassif Haddad, et al.Cancers|March 13, 2024
The Future of Targeted Therapy for LeiomyosarcomaRyan A Denu, Amanda M Dann, Emily Z Keung, et al.Diagnostics (Basel, Switzerland)|September 28, 2024
Predictive Value of Quantitative Parameters of 18F-FDG PET/CT in Patients with LiposarcomaLucia Martiniova, Serageldin Kamel, Kalevi Kairemo, et al.Pageof 4